N-Butyl-2-cyanoacrylate-based injectable and in situ-forming implants for efficient intratumoral chemotherapy

References

• Arzoo K, Sadeghi S, Liebman HA. (2002). Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab). Ann Rheum Dis 61:922–4
   PubMed Web of Science ®Google Scholar
• Braig F, Marz M, Schieferdecker A, et al. (2015). Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer. Oncotarget 6:12035–47
   PubMed Web of Science ®Google Scholar
• Casuso P, Odriozola I, Perez-San Vicente A, et al. (2015). Injectable and self-healing dynamic hydrogels based on metal(I)-thiolate/disulfide exchange as biomaterials with tunable mechanical properties. Biomacromolecules 16:3552–61
   PubMed Web of Science ®Google Scholar
• Chakravarty R, Hong H, Cai W. (2015). Image-guided drug delivery with single-photon emission computed tomography: a review of literature. Curr Drug Targets 16:592–609
   PubMed Web of Science ®Google Scholar
• Dieli-Conwright CM, Mortimer JE, Schroeder ET, et al. (2014). Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods. BMC Cancer 14:238
   PubMed Web of Science ®Google Scholar
• Duffner F, Ritz R, Bornemann A, et al. (2002). Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA). Clin Neuropathol 21:13–17
   PubMed Web of Science ®Google Scholar
• Durymanov MO, Rosenkranz AA, Sobolev AS. (2015). Current approaches for improving intratumoral accumulation and distribution of nanomedicines. Theranostics 5:1007–20
   PubMed Web of Science ®Google Scholar
• Duvillard C, Polycarpe E, Romanet P, et al. (2007). Intratumoral chemotherapy: experimental data and applications to head and neck tumors. Ann Otolaryngol Chir Cervicofac 124:53–60
   PubMedGoogle Scholar
• El-Kareh AW, Secomb TW. (2000). A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells. Neoplasia 2:325–38
   PubMed Web of Science ®Google Scholar
• Giorgio A. (2010). Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a simple, effective and cheap procedure for percutaneous ablation. J Gastrointestin Liver Dis 19:461–2
   PubMed Web of Science ®Google Scholar
• Guan YS, He Q, Wang MQ. (2012). Transcatheter arterial chemoembolization: history for more than 30 years. ISRN Gastroenterol 2012:480650
   PubMedGoogle Scholar
• Han K, Kim JH, Yoon HM, et al. (2014). Transcatheter arterial chemoembolization for infiltrative hepatocellular carcinoma: clinical safety and efficacy and factors influencing patient survival. Korean J Radiol 15:464–71
   PubMed Web of Science ®Google Scholar
• Huh KM, Lee SC, Cho YW, et al. (2005). Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release 101:59–68
   PubMed Web of Science ®Google Scholar
• Huynh CT, Nguyen MK, Jeong IK, et al. (2012). Synthesis, characteristics and potential application of poly(beta-amino ester urethane)-based multiblock co-polymers as an injectable, biodegradable and pH/temperature-sensitive hydrogel system. J Biomater Sci Polym Ed 23:1091–106
   PubMed Web of Science ®Google Scholar
• Jain RK. (1998). Delivery of molecular and cellular medicine to solid tumors. J Control Release 53:49–67
   PubMed Web of Science ®Google Scholar
• Jeong B, Kim SW, Bae YH. (2002). Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 54:37–51
   PubMed Web of Science ®Google Scholar
• Kanekal S, Joo J, Bublik M, et al. (2009). Retention of intratumor injections of cisplatinum in murine tumors and the impact on laser thermal therapy for cancer treatment. Eur Arch Otorhinolaryngol 266:279–84
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim KS, Kang YM, et al. (2010). In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth. Int J Pharm 392:51–6
   PubMed Web of Science ®Google Scholar
• Li X, Weng Y, Kong X, et al. (2012). A covalently crosslinked polysaccharide hydrogel for potential applications in drug delivery and tissue engineering. J Mater Sci Mater Med 23:2857–65
   PubMed Web of Science ®Google Scholar
• Lin Z, Gao W, Hu H, et al. (2014). Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: high drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. J Control Release 174:161–70
   PubMed Web of Science ®Google Scholar
• Liu S, Kurzrock R. (2015). Understanding toxicities of targeted agents: implications for anti-tumor activity and management. Semin Oncol 42:863–75
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. (2003). Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–42
   PubMed Web of Science ®Google Scholar
• Lu C, Wang X, Wu G, et al. (2014). An injectable and biodegradable hydrogel based on poly(α,β-aspartic acid) derivatives for localized drug delivery. J Biomed Mater Res A 102:628–38
   PubMed Web of Science ®Google Scholar
• Madan M, Bajaj A, Lewis S, et al. (2009). In situ forming polymeric drug delivery systems. Indian J Pharm Sci 71:242–51
   PubMed Web of Science ®Google Scholar
• Maluccio M, Covey A. (2012). Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin 62:394–9
   PubMed Web of Science ®Google Scholar
• Mamot C, Drummond DC, Noble CO, et al. (2005). Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res 65:11631–8
   PubMed Web of Science ®Google Scholar
• Mayor S. (2006). NICE approves trastuzumab for early stage breast cancer. BMJ 332:1409
   PubMed Web of Science ®Google Scholar
• Morton RJ, Gibson MF, Sloan JP. (1988). The use of histoacryl tissue adhesive for the primary closure of scalp wounds. Arch Emerg Med 5:110–12
   PubMedGoogle Scholar
• Mosli MH, Aljudaibi B, Almadi M, et al. (2013). The safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single Canadian tertiary care centre. Saudi J Gastroenterol 19:152–9
   PubMed Web of Science ®Google Scholar
• Namkung S, Chu CC. (2007). Partially biodegradable temperature-and pH-responsive poly(N-isopropylacrylamide)/dextran-maleic acid hydrogels: formulation and controlled drug delivery of doxorubicin. J Biomater Sci Polym Ed 18:901–24
   PubMed Web of Science ®Google Scholar
• Nishimura T, Nakamura K, Yamashita S, et al. (2015). Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor. BMC Cancer 15:957
   PubMed Web of Science ®Google Scholar
• Sathornsumetee S, Rich JN. (2006). New approaches to primary brain tumor treatment. Anticancer Drugs 17:1003–16
   PubMed Web of Science ®Google Scholar
• Solano AG, de Fatima Pereira A, Pinto FC, et al. (2013). Development and evaluation of sustained-release etoposide-loaded poly(epsilon-caprolactone) implants. AAPS PharmSciTech 14:890–900
   PubMed Web of Science ®Google Scholar
• Tomita Y, Rikimaru-Kaneko A, Hashiguchi K, et al. (2011). Effect of anionic and cationic n-butylcyanoacrylate nanoparticles on NO and cytokine production in Raw264.7 cells. Immunopharmacol Immunotoxicol 33:730–7
   PubMed Web of Science ®Google Scholar
• Weinberg BD, Blanco E, Gao J. (2008). Polymer implants for intratumoral drug delivery and cancer therapy. J Pharm Sci 97:1681–702
   PubMed Web of Science ®Google Scholar
• Xie H, Goins B, Bao A, et al. (2012). Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells. Int J Nanomed 7:2227–38
   PubMed Web of Science ®Google Scholar
• Yamashita N, Saitou K, Takagi A, et al. (2009). Preparation and characterization of gelatin sponge millispheres injectable through microcatheters. Med Devices (Auckl) 2:19–25
   PubMedGoogle Scholar
• Yang Y, El Haj AJ. (2006). Biodegradable scaffolds-delivery systems for cell therapies. Expert Opin Biol Ther 6:485–98
   PubMed Web of Science ®Google Scholar